Not applicableStudy completedNCT04938141What this trial is testingMEOI and HRQoL in CLL Patients Treated With BTKisWho this might be right forChronic Lymphocytic Leukemia AstraZeneca 23
Testing effectiveness (Phase 2)UnknownNCT03891355What this trial is testingCarfilzomib + Lenalidomide and Dexamethasone for BTK Inhibitors Relapsed-refractory or Intolerant MCLWho this might be right forMantle Cell Lymphoma Fondazione Italiana Linfomi - ETS 16
Not applicableLooking for participantsNCT06508684What this trial is testingCurrent Status of BTKi Treatment for CLL/SLL in ChinaWho this might be right forCLL/SLL The First Affiliated Hospital with Nanjing Medical University 1,000
Not applicableUnknownNCT05284175What this trial is testingOrelabrutinib in Patients With AQP4-IgG Positive Neuromyelitis Optica Spectrum DisorderWho this might be right forNeuromyelitis Optica Spectrum Disorder Peking Union Medical College Hospital 23
Not applicableLooking for participantsNCT06151730What this trial is testingEvaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT StudyWho this might be right forChronic Lymphocytic LeukemiaHematopoietic and Lymphoid System NeoplasmMantle Cell Lymphoma+2 more Mayo Clinic 100
Not applicableActive Not RecruitingNCT04882475What this trial is testingBiological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.Who this might be right forMantle Cell Lymphoma Fondazione Italiana Linfomi - ETS 160
Not applicableLooking for participantsNCT05724121What this trial is testingObservational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or VenetoclaxWho this might be right forChronic Lymphocytic Leukemia (CLL)Waldenstr(SqrRoot)(Delta)m s MacroglobulinemiaMantle Cell Lymphoma+3 more National Heart, Lung, and Blood Institute (NHLBI) 135
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06890585What this trial is testingZanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCLWho this might be right forBTK InhibitorsHistone Deacetylase InhibitorDouble Express Diffuse Large B-cell Lymphoma Li Zhiming 128
Not applicableLooking for participantsNCT05506410What this trial is testingA Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell LymphomaWho this might be right forNewly Diagnosed Mantle Cell Lymphoma Zhengzhou University 100
Very early researchStudy completedNCT03771157What this trial is testingSerologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK InhibitorsWho this might be right forChronic Lymphocytic Leukemia (CLL)Waldenstrom Macroglobulinemia (WM) University of Rochester 33
Testing effectiveness (Phase 2)Looking for participantsNCT07371923What this trial is testingApplication of Zanubrutinib-based Combination Regimens in the Treatment of Newly-diagnosed Diffuse Large B-cell LymphomaWho this might be right forDiffuse Large B Cell Lymphoma (DLBCL) Beijing Tongren Hospital 50
Not applicableStudy completedNCT05555979What this trial is testingAssess Change in Patient Experience in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets + Intravenous Rituximab or Bruton's Tyrosine Kinase Inhibitors Tablets in the United KingdomWho this might be right forChronic Lymphocytic Leukemia AbbVie 56
Not applicableLooking for participantsNCT07174141What this trial is testingInnovative Biomarkers of Cardiovascular Complications Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Treatments: a Single-center Cohort StudyWho this might be right forTreatment With Second-generation Bruton's Tyrosine Kinase Inhibitors (Acalabrutinib, Zanubrutinib) Centre Hospitalier Universitaire Dijon 100
Testing effectiveness (Phase 2)Looking for participantsNCT05249959What this trial is testingConsolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients.Who this might be right forRelapsed Mantle Cell LymphomaRefractory Mantle Cell Lymphoma Fondazione Italiana Linfomi - ETS 49
Not applicableNot Yet RecruitingNCT07283965What this trial is testingZanubrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell MalignanciesWho this might be right forChronic B-cell MalignanciesBTK InhibitorsCardiovascular Diseases University Hospital, Caen 15,000
Not applicableUnknownNCT06130709What this trial is testingIRAF-ABLATION Study: a Multicenter International Retrospective Cohort of Patients With BTK Inhibitors-related AF Treated by Catheter AblationWho this might be right forBTKi-induced Atrial FibrillationHematologic MalignancyAtrial Fibrillation Catheter Ablation University Hospital, Caen 100
Not applicableUnknownNCT05495828What this trial is testingOrelabrutinib Therapy in Patients With r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase InhibitorsWho this might be right forB-cell Lymphoma Peking University People's Hospital 30
Not applicableEnrolling By InvitationNCT06211413What this trial is testingHypertension and Arrhythmias in CLL Patients Treated with BTK InhibitorsWho this might be right forChronic Lymphocytic LeukemiaAtrial FibrillationHypertension+1 more Abramson Cancer Center at Penn Medicine 50
Testing effectiveness (Phase 2)UnknownNCT04831658What this trial is testingA Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System LymphomaWho this might be right forPrimary Central Nervous System Lymphoma Mingzhi Zhang 40
Large-scale testing (Phase 3)Study completedNCT03053440What this trial is testingA Study Comparing BGB-3111 and Ibrutinib in Participants With Waldenström's Macroglobulinemia (WM)Who this might be right forWaldenström's Macroglobulinemia BeiGene 201